首页> 美国卫生研究院文献>Acta Bio Medica : Atenei Parmensis >CT-guided radiofrequency ablation of osteoid osteoma using a multi-tined expandable electrode system
【2h】

CT-guided radiofrequency ablation of osteoid osteoma using a multi-tined expandable electrode system

机译:使用多通道可扩展电极系统的CT引导的类骨性骨瘤射频消融

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and aim of the work: Radiofrequency ablation (RFA) is the gold standard for the treatment of symptomatic osteoid osteoma (OO) as RFA yields both a high success and low complication rate. It has been widely utilized over the years, but recurrences of OO after this treatment have been documented. These recurrences may be the result of various factors, including incomplete tumor ablation, and are significantly higher in lesions greater than 10 mm. Thus, the need to induce thermal ablation in a wider area led us to use a Multi-Tined Expandable Electrode System (MTEES). In this study we examined the efficacy and safety of RFA using a MTEES in symptomatic OO. Methods: Between January 2005 and June 2007, 16 patients with symptomatic OO were treated by CT-guided percutaneous RFA using a MTEES. The diameter of OO ranged from 6 to 15 mm (mean 10±2.6 mm). Patients were evaluated for clinical outcomes, complications and recurrence. Pain evaluation was assessed preoperatively, 2 weeks postoperatively and at last follow-up. Results: Clinical follow-up was available for all patients at a mean of 84.3 months (range 73-96 months). Mean preoperative VAS score was 7.4 (range 5-9), two weeks after the procedure mean VAS score was 0.3 (range 0-1) with a mean change of -7.06 points (p<0.0001). At the last follow-up a complete relief from pain has been observed in all patients. No major and minor complications were observed nor recurrences. Conclusions: RFA using a MTEES has been effective, safe and reliable for the treatment of OOs. This system, by increasing the size of the necrosis, could be a viable alternative to the single needle electrode in lesions larger than 10 mm, reducing the risk of recurrence. ()
机译:工作的背景和目的:射频消融(RFA)是治疗有症状的骨样骨瘤(OO)的金标准,因为RFA既有很高的成功率,也有较低的并发症发生率。多年来,它已被广泛利用,但已有文献报道这种治疗后OO的复发。这些复发可能是多种因素导致的,包括肿瘤切除不完全,并且在大于10 mm的病变中明显更高。因此,在更广泛的区域中引发热消融的需要导致我们使用了多片可扩展电极系统(MTEES)。在这项研究中,我们检查了在有症状的OO中使用MTEES进行RFA的有效性和安全性。方法:2005年1月至2007年6月,采用MTEES的CT引导经皮RFA治疗16例有症状的OO患者。 OO的直径范围为6至15毫米(平均10±2.6毫米)。对患者的临床结局,并发症和复发进行了评估。术前,术后2周以及最后一次随访时评估疼痛评估。结果:所有患者的平均临床随访时间为84.3个月(范围73-96个月)。术前平均VAS评分为7.4(范围5-9),术后2周平均VAS评分为0.3(范围0-1),平均变化为-7.06分(p <0.0001)。在最后一次随访中,在所有患者中均观察到疼痛完全缓解。没有观察到主要和次要并发症,也没有复发。结论:使用MTEES的RFA治疗OOs是有效,安全和可靠的。通过增加坏死的大小,该系统可以替代大于10 mm的病灶中的单针电极,从而降低复发风险。 ()

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号